CLAYTON MILLER: Open Payments
NPI 1649700378 · RICHMOND HILL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 24 payments from 15 companies in 2025. Trend: 2023 $1,763 · 2024 $1,895 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Amgen Inc. | 3 | $52 |
| Novo Nordisk Inc | 3 | $50 |
| SANOFI-AVENTIS U.S. LLC | 2 | $47 |
| Eisai Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $21 |
Products named: UBRELVY, CAPLYTA, TZIELD, Ozempic, Leqembi, MOUNJARO, REXULTI, SPRAVATO.
Industry payments across GA — which companies pay providers there.
